Brief: Abbvie And Xilio Therapeutics Announce Collaboration
12/02/2025 12:51
Feb 12 (Reuters) - Abbvie ABBV.N :
* ABBVIE AND XILIO THERAPEUTICS ANNOUNCE COLLABORATION AND
OPTION
AGREEMENT TO DEVELOP NOVEL TUMOR-ACTIVATED IMMUNOTHERAPIES
Source text: ID:nGNX9jY2Q7
Further company coverage: ABBV.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla